Safe self-destruction syringe

By automatically breaking when the push rod device of the syringe is pulled out, the cross-infection problem caused by residual and reuse of the drug solution is solved, ensuring that the syringe is used once and improving the safety of medical injections.

CN118903604APending Publication Date: 2024-11-08SHANDONG RUYUE MEDICAL TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411147089.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing syringes may have residual liquid after use, which increases the risk of reuse and lacks a one-time use mechanism, resulting in potential cross-infection.

Method used

A safe self-destructive syringe is designed to automatically break when the push rod device is pulled out, ensuring that the syringe fails immediately after one-time use, including injection cannula, needle device and push rod device, the second end of the injection cannula A blocking structure is provided, which breaks the pushing rod device when it is pulled out to prevent reuse.

Benefits of technology

Effectively prevent reuse of syringes, reduce the risk of cross-infection, ensure the single use of syringes, and improve the safety of medical injections.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903604A_ABST
    Figure CN118903604A_ABST
Patent Text Reader

Abstract

The invention discloses a safe self-destruction syringe, and relates to the technical field of medical instruments, the safe self-destruction syringe comprises an injection sleeve, a needle device and a push rod device, the injection sleeve is provided with a first end and a second end, and the first end and the second end are communicated with the interior of the injection sleeve; the needle device is installed at the first end of the injection sleeve and connected with the injection sleeve in a sealed mode. The push rod device is arranged in the injection sleeve from the second end of the injection sleeve, the push rod device is in sealing contact with the injection sleeve, and a sealed solution space is formed between the needle head device and the push rod device; wherein the second end of the injection sleeve is provided with a blocking structure, and the blocking structure is used for breaking the push rod device when the push rod device is pulled out of the second end of the injection sleeve. According to the safe self-destruction syringe, automatic breaking is achieved when the push rod device is pulled out, it is ensured that the syringe fails immediately after being used once, the syringe can be effectively prevented from being repeatedly used, and the cross infection risk is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of medical devices, and in particular to a safe self-destructive syringe. Background Art

[0002] As a widely used device in the medical field, the main function of syringes is to inject liquid medicine into human tissues, subcutaneous tissues, blood vessels or muscles through acupuncture technology. Traditional syringes are simple in design and easy to operate, but with the improvement of medical safety standards, their safety issues have gradually received attention.

[0003] Although existing syringes play an important role in medical practice, they have some obvious defects. First, ordinary syringes may have residual liquid medicine after use, increasing the risk of reuse. Second, due to the lack of an effective disposable mechanism, these syringes may be improperly reused, increasing the risk of cross-infection. These problems highlight the shortcomings of existing technologies in terms of safety and disposable use. Summary of the invention

[0004] The purpose of the present application is to provide a safe self-destructive syringe, which can automatically break when the push rod device is pulled out to ensure that the syringe becomes invalid immediately after a single use, effectively prevent the syringe from being reused, and reduce the risk of cross infection.

[0005] To achieve the above objectives, the present application provides a safe self-destructive syringe, comprising:

[0006] An injection sleeve having a first end and a second end in communication with the interior thereof;

[0007] A needle device is mounted on the first end of the injection sleeve, and the needle device is sealed and connected to the injection sleeve;

[0008] A push rod device is installed into the injection sleeve from the second end of the injection sleeve, the push rod device is in sealing contact with the injection sleeve and forms a sealed solution space between the needle device and the push rod device;

[0009] Wherein, the second end of the injection sleeve is provided with a blocking structure, and the blocking structure is used to break the push rod device when the push rod device is pulled out from the second end of the injection sleeve.

[0010] In some embodiments, the push rod device comprises:

[0011] A push head member, in sealing contact with the injection sleeve;

[0012] A push rod member is connected to the push head member, and the push rod member is used to break when the push rod member is pulled out from the second end of the injection sleeve.

[0013] In some embodiments, the push rod member is provided with a stop structure and a pre-break structure, wherein the stop structure is used to be restricted by the blocking structure when the push rod member is pulled out from the second end of the injection sleeve, so as to break the pre-break structure.

[0014] In some embodiments, the push rod member includes a first rod body and a second rod body, the first end of the first rod body is connected to the push head member, the first rod body is provided with the stopping structure, the second end of the first rod body is connected to the first end of the second rod body through the pre-breaking structure, and the second end of the second rod body is located outside the injection sleeve.

[0015] In some embodiments, the needle device comprises:

[0016] The spiral needle seat is sealed and connected to the injection sleeve. The spiral needle seat is provided with a threaded hole for mounting a needle in a direction away from the second end of the injection sleeve.

[0017] In some embodiments, the spiral needle holder is assembled with the injection cannula;

[0018] The spiral needle seat and the injection sleeve are interference fit, and / or a connection point is provided at the assembly position of the spiral needle seat and the injection sleeve.

[0019] In some embodiments, the spiral needle seat is provided with a slot structure in the direction facing the second end of the injection sleeve, and the slot structure is used to be buckled and fixed with the push rod device when the push rod device is pushed into place toward the first end of the injection sleeve.

[0020] In some embodiments, the push rod device includes a first rod body provided with a clamping head structure and a stopper structure at a first end, wherein the clamping head structure is used to be clamped and fixed with the clamping slot structure after passing through the spiral needle seat;

[0021] The push rod device also includes a second rod body connected to the second end of the first rod body through a pre-breaking structure at a first end;

[0022] Wherein, after the needle is installed on the spiral needle seat, the first force acting on the spiral needle seat due to the needle puncture is F1; the second force acting on the spiral needle seat due to the injection sleeve assembly is F2; ​​the first force F1 is not greater than the second force F2;

[0023] After the clamping head structure is clamped into the clamping slot structure, the third force acting on the spiral needle seat under the pulling action of the first rod body is F3; the third force F3 is greater than the second force F2;

[0024] The fourth force when the pre-breaking structure breaks is F4; the fifth force on the stopping structure blocked by the blocking structure is F5; the fourth force F4 is greater than the third force F3, and the fourth force F4 is less than the fifth force F5.

[0025] In some embodiments, the push rod device includes a push head member and a push rod member provided with a first rod body, the first end of the first rod body is provided with a clamping structure, a mounting structure and a stopping structure in sequence, the push head member is sleeved on the mounting structure, and the push head member is provided with a through hole for the clamping structure to pass through.

[0026] In some embodiments, the push rod device includes a push rod member and a stop structure removably arranged on the push rod member, wherein the stop structure is located outside the injection sleeve, and the stop structure is used to prevent the push rod device from being accidentally pushed by contacting the injection sleeve when it is not removed.

[0027] Compared with the above-mentioned background technology, the safety self-destructive syringe provided by the present application mainly includes an injection sleeve, a needle device and a push rod device, wherein the injection sleeve is provided with a first end and a second end connected to the interior thereof; the needle device is installed at the first end of the injection sleeve, and the needle device is sealedly connected to the injection sleeve; the push rod device is inserted into the interior of the injection sleeve from the second end of the injection sleeve, the push rod device is in sealing contact with the injection sleeve and a sealed solution space is formed between the needle device and the push rod device; wherein the second end of the injection sleeve is provided with a blocking structure, and the blocking structure is used to break the push rod device when the push rod device is pulled out from the second end of the injection sleeve.

[0028] In existing medical practices, the safety issues of syringes are mainly reflected in the residual and reuse of liquid medicine, which not only increases the risk of cross infection, but also poses a threat to the health of medical staff and patients. In response to this problem, the safe self-destructive syringe provided in this application has achieved significant improvements over the prior art through carefully designed components and structures. The core components of the syringe include an injection sleeve, a needle device and a push rod device. The injection sleeve is designed with two end points. The first end is connected to the needle device to ensure that the liquid medicine can be safely transmitted to the injection site; the second end is used to load the push rod device, and the sealing of the liquid medicine is maintained through sealing contact, forming a closed solution space to prevent liquid medicine leakage or external contamination.

[0029] The most critical innovation lies in the blocking structure at the second end of the injection sleeve and the breaking effect of the blocking structure on the push rod device. This structure is cleverly designed to trigger the automatic breaking mechanism when the push rod device completes the injection and is pulled out. The setting of the blocking structure ensures that once the push rod device is pulled out, it will break immediately, making it impossible to push the syringe back or use it again. This self-destruction mechanism effectively avoids the reuse of syringes and greatly reduces the risk of cross infection caused by improper handling or storage of syringes.

[0030] In combination with the above structure and process description, it can be seen that the safety self-destructive syringe has at least the following beneficial effects: the safety self-destructive syringe automatically breaks when the push rod device is pulled out, ensuring that the syringe becomes invalid immediately after a single use, which can effectively prevent the syringe from being reused and reduce the risk of cross infection. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying any creative work.

[0032] Figure 1 A first schematic diagram of a safety self-destructive syringe provided in an embodiment of the present application;

[0033] Figure 2 A second schematic diagram of a safety self-destructive syringe provided in an embodiment of the present application;

[0034] Figure 3 A third schematic diagram of a safety self-destructive syringe provided in an embodiment of the present application;

[0035] Figure 4 A schematic diagram of a needle device and a push rod device provided in an embodiment of the present application;

[0036] Figure 5 A schematic diagram of a push rod device provided in an embodiment of the present application;

[0037] Figure 6 A schematic diagram of a needle device provided in an embodiment of the present application;

[0038] Figure 7 for Figure 2 Magnified view of the mid-needle assembly.

[0039] in:

[0040] Injection sleeve 1, blocking structure 11, needle device 2, spiral needle seat 21, threaded hole 211, slot structure 212, push rod device 3, push head member 31, push rod member 32, first rod body 321, second rod body 322, stop structure 33, pre-breaking structure 34, clamping head structure 35, installation structure 36, stop structure 37. DETAILED DESCRIPTION

[0041] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0042] In order to enable those skilled in the art to better understand the present application, the present application is further described in detail below in conjunction with the accompanying drawings and specific implementation methods.

[0043] Please refer to Figure 1 and Figure 2 , Figure 1 This is a first schematic diagram of a safety self-destructive syringe provided in an embodiment of the present application. Figure 2 This is a second schematic diagram of the safety self-destructive syringe provided in an embodiment of the present application.

[0044] In a first specific embodiment, Figure 1 As shown, the safety self-destructive syringe provided by the embodiment of the present application mainly includes an injection sleeve 1, a needle device 2 and a push rod device 3. The injection sleeve 1 is provided with a first end and a second end connected to the interior thereof, and the injection sleeve 1 stores injection liquid; the needle device 2 is installed at the first end of the injection sleeve 1, and the needle device 2 is sealedly connected to the injection sleeve 1; the push rod device 3 is inserted into the interior of the injection sleeve 1 from the second end of the injection sleeve 1, and the push rod device 3 is in sealing contact with the injection sleeve 1 and a sealed solution space is formed between the needle device 2 and the push rod device 3; wherein, the second end of the injection sleeve 1 is provided with a blocking structure 11, and the blocking structure 11 is used to break the push rod device 3 when the push rod device 3 is pulled out from the second end of the injection sleeve 1.

[0045] like Figure 2 As shown, when the push rod device 3 is pulled out from the second end of the injection sleeve 1, the push rod device 3 is additionally blocked by the blocking structure 11, so that the push rod device 3 is broken, thereby preventing the push rod device 3 from being completely pulled out, thereby achieving the purpose of preventing reuse.

[0046] In existing medical practices, the safety issues of syringes are mainly reflected in the residual and reuse of liquid medicine, which not only increases the risk of cross infection, but also poses a threat to the health of medical staff and patients. In response to this problem, the safe self-destructive syringe provided in this application has achieved significant improvements over the prior art through carefully designed components and structures. The core components of the syringe include an injection sleeve 1, a needle device 2 and a push rod device 3. The injection sleeve 1 is designed with two end points. The first end is connected to the needle device 2 to ensure that the liquid medicine can be safely transmitted to the injection site; the second end is used to load the push rod device 3, and maintain the sealing of the liquid medicine through sealing contact, forming a closed solution space to prevent liquid medicine leakage or external contamination.

[0047] The most critical innovation lies in the blocking structure 11 at the second end of the injection sleeve 1 and the breaking effect of the blocking structure 11 on the push rod device 3. This structure is ingeniously designed, and can trigger the automatic breaking mechanism when the push rod device 3 completes the injection and is pulled out. The setting of the blocking structure 11 ensures that once the push rod device 3 is pulled out, it will break immediately, making it impossible for the syringe to be pushed back or used again. This self-destruction mechanism effectively avoids the reuse of syringes and greatly reduces the risk of cross infection caused by improper handling or storage of syringes.

[0048] In combination with the above structure and process description, it can be seen that the safety self-destructive syringe has at least the following beneficial effects: the safety self-destructive syringe automatically breaks when the push rod device 3 is pulled out, ensuring that the syringe becomes invalid immediately after a single use, which can effectively prevent the syringe from being reused and reduce the risk of cross infection.

[0049] In a specific embodiment, the safety self-destructing syringe can also realize the function of needle retraction. Figure 2 And refer to Figure 3 , Figure 3 This is a third schematic diagram of the safety self-destructive syringe provided in an embodiment of the present application.

[0050] like Figure 3 As shown, the push rod device 3 is pushed into place in the injection sleeve 1, which is equivalent to completing the injection of the liquid medicine. At this time, the push rod device 3 is connected to the needle device 2 as a whole. When the push rod device 3 is pulled back, as shown in FIG. Figure 2 As shown, the push rod device 3 drives the needle device 2 to retreat, and the needle device 2 is now retreated into the injection sleeve 1, which can avoid the exposure of the discarded needle after use.

[0051] In some cases, safety self-destruct syringes combine single-use and needle-retractability features.

[0052] Please refer to Figure 4 , Figure 4Schematic diagram of the needle device and the push rod device provided in the embodiment of the present application.

[0053] In some embodiments, the push rod device 3 comprises:

[0054] The push head member 31 is in sealing contact with the injection sleeve 1;

[0055] The push rod member 32 is connected to the push head member 31 , and the push rod member 32 is used to break when the push rod member 32 is pulled out from the second end of the injection sleeve 1 .

[0056] In this embodiment, the push rod device 3 is one of the key components of the self-destructive syringe, and its design ensures the disposable use of the syringe, thereby preventing reuse and potential cross infection. The push rod device 3 is composed of two main parts: a push head 31 and a push rod 32.

[0057] The pusher head 31 is the front end of the push rod device 3. Its basic function is equivalent to the rubber plug inside the syringe. It is in sealing contact with the inside of the injection sleeve 1. This sealing contact ensures that the liquid medicine will not leak during the injection process, and also ensures the stability of the syringe during use. The design of the pusher head 31 and the sealing cooperation with the injection sleeve 1 are the basis for achieving safe transmission of the liquid medicine.

[0058] The push rod member 32 is the rear end portion of the push rod device 3, and is connected to the push head member 31 to form the overall structure of the push rod device 3. The design of the push rod member 32 is special, and it can be automatically broken when it is pulled out from the second end of the injection sleeve 1. This self-destruction mechanism is one of the core innovations of the present technical solution, which ensures that the syringe cannot be pushed back or used again after use, thereby avoiding the reuse of the syringe.

[0059] Through this design, the push rod device 3 not only plays a role in pushing the liquid medicine during the injection process, but also realizes the disposable use of the syringe through its self-destruction mechanism after the injection is completed. This mechanism effectively reduces the risk of cross infection caused by improper handling or storage of the syringe and improves the safety of medical injection.

[0060] Please refer to Figure 5 , Figure 5 A schematic diagram of a push rod device provided in an embodiment of the present application.

[0061] In some embodiments, the push rod 32 is provided with a stop structure 33 and a pre-break structure 34 , and the stop structure 33 is used to be restricted by the blocking structure 11 when the push rod 32 is pulled out from the second end of the injection sleeve 1 , so as to break the pre-break structure 34 .

[0062] In this embodiment, the design of the push rod member 32 is further refined, and a stop structure 33 and a pre-break structure 34 are introduced. These two structures are crucial for realizing the self-destruction function of the syringe.

[0063] The main function of the stop structure 33 is to interact with the blocking structure 11 when the push rod 32 is pulled out of the second end of the injection sleeve 1. When the push rod 32 tries to be pulled out, the stop structure 33 first contacts the blocking structure 11. This design ensures that when the push rod 32 continues to be pulled out, it will encounter resistance from the blocking structure 11, thereby triggering the breaking of the pre-breaking structure 34.

[0064] The pre-break structure 34 is a weak point in the push rod 32, and is designed to be easily broken under certain conditions. When the push rod 32 continues to be subjected to tension due to the restriction of the stop structure 33, the pre-break structure 34 will break because the force exceeds its designed strength. This breaking mechanism ensures that the push rod 32 is pulled out and broken after the injection is completed, realizing the disposable use of the syringe.

[0065] Through the synergistic effect of the stop structure 33 and the pre-break structure 34, the push rod 32 can automatically break after completing its function of pushing the liquid medicine, thereby preventing the syringe from being reused. This design not only improves the safety of the syringe, but also reduces the risk of cross infection by preventing reuse.

[0066] Please continue to refer to Figure 4 and Figure 5 In some embodiments, the push rod member 32 includes a first rod body 321 and a second rod body 322, the first end of the first rod body 321 is connected to the push head member 31, a stopping structure 33 is provided on the first rod body 321, the second end of the first rod body 321 is connected to the first end of the second rod body 322 through a pre-breaking structure 34, and the second end of the second rod body 322 is located outside the injection sleeve 1.

[0067] In this embodiment, the push rod member 32 is divided into two parts in the overall structure, namely, a first rod body 321 and a second rod body 322. The first rod body 321 is the first part of the push rod member 32, and one end of the first rod body 321 is connected to the push head member 31 to form a continuous structure of the push rod device 3. A stop structure 33 is provided on the first rod body 321. The function of the stop structure 33 is to interact with the blocking structure 11 of the injection sleeve 1 when the push rod member 32 is pulled out from the second end of the injection sleeve 1, and to provide necessary resistance to ensure that the pre-breaking structure 34 breaks at an appropriate time. When the pre-breaking structure 34 breaks, the first rod body 321 remains in the injection sleeve 1.

[0068] The second rod 322 is the second part of the push rod 32, and the pre-breaking structure 34 is a component connecting the first rod 321 and the second rod 322, and is designed to be easily broken under certain conditions. The second end of the first rod 321 is connected to the first end of the second rod 322 through the pre-breaking structure 34. This connection method allows the pre-breaking structure 34 to break when the push rod 32 is pulled out under sufficient tension, thereby separating the first rod 321 from the second rod 322. When the pre-breaking structure 34 breaks, the second rod 322 will be separated from the injection sleeve 1 and cannot be inserted again, thereby ensuring that the syringe cannot be reused.

[0069] Through this design, the push rod 32 not only plays a role in pushing the liquid medicine during the injection process, but also realizes the disposable use of the syringe through its self-destruction mechanism after the injection is completed. This mechanism effectively reduces the risk of cross infection caused by improper handling or storage of the syringe and improves the safety of medical injection.

[0070] In some cases, after the injection of the liquid medicine, the first rod 321 can be left in the injection sleeve 1 by pulling it out quickly with a certain force, and the pre-breaking structure 34 is broken at the same time, and the second rod 322 is separated from the first rod 321 to avoid secondary use.

[0071] Please refer to Figure 6 , Figure 6 A schematic diagram of a needle device provided in an embodiment of the present application.

[0072] In some embodiments, the needle device 2 comprises:

[0073] The spiral needle seat 21 is sealed and connected to the injection sleeve 1 . The spiral needle seat 21 is provided with a threaded hole 211 for mounting a needle in a direction facing away from the second end of the injection sleeve 1 .

[0074] In this embodiment, the needle device 2 is a key part of the syringe, which is responsible for transmitting the drug solution to the injection site. The needle device 2 is composed of a spiral needle seat 21, which is sealed with the injection sleeve 1 to ensure that the drug solution will not leak out during the injection process and keep the sterile state inside the syringe.

[0075] The spiral needle seat 21 is designed with a special structure, and a threaded hole 211 is provided in the direction facing away from the second end of the injection sleeve 1. The threaded hole 211 is a key part for installing the needle, and the needle can be firmly fixed on the spiral needle seat 21 through a threaded connection. Such a design not only facilitates the installation and replacement of the needle, but also ensures the stability and safety of the needle during use.

[0076] In addition, the sealed connection design of the spiral needle seat 21 also takes into account the tight fit with the injection sleeve 1. Through such interference fit or sealing ring mechanisms, the drug liquid can be effectively prevented from leaking, ensuring the safety and reliability of the injection process. This design is crucial to preventing cross infection and ensuring the sanitary conditions of medical operations.

[0077] In some embodiments, the spiral needle seat 21 is assembled with the injection sleeve 1 to ensure that the injection sleeve 1 can provide sufficient assembly force to the spiral needle seat 21 to avoid unnecessary movement of the spiral needle seat 21. There are many ways to assemble the spiral needle seat 21 with the injection sleeve 1, including but not limited to interference fit and adding connection points to achieve fit.

[0078] Optionally, the spiral needle seat 21 is interference fit with the injection sleeve 1 , and a connection point is provided at the assembly position of the spiral needle seat 21 and the injection sleeve 1 .

[0079] It should be noted that the connection point can be set on the spiral needle seat 21 or on the injection sleeve 1, and both belong to the description scope of this embodiment.

[0080] Optionally, in addition to the connection points, grooves corresponding to the connection points are also provided, and the connection point fit is achieved by means of the concave-convex fit between the connection points and the grooves.

[0081] Interference fit is a common connection method in mechanical design. By making the size of one component slightly larger than the corresponding size of the other component, a certain interference is generated during assembly, allowing the two components to be tightly combined.

[0082] This interference fit design ensures that the connection between the spiral needle seat 21 and the injection sleeve 1 is both firm and sealed, preventing the leakage of the liquid medicine during the injection process, while also avoiding the invasion of external contaminants, ensuring the safety and sterility of the syringe. In addition, the interference fit also helps to maintain the stability of the needle during the injection process, reducing the risk of needle displacement or falling off due to changes in injection force or angle.

[0083] Through this design, the spiral needle seat 21 can not only be reliably connected to the injection sleeve 1, but also effectively support the needle to ensure the accuracy and safety of the injection process. This close matching mode plays a vital role in improving the performance and reliability of the entire syringe.

[0084] Please continue to refer to Figure 3 and Figure 6 In some embodiments, the spiral needle seat 21 is provided with a slot structure 212 in the direction facing the second end of the injection sleeve 1, and the slot structure 212 is used to be buckled and fixed with the push rod device 3 when the push rod device 3 is pushed into place toward the first end of the injection sleeve 1.

[0085] In this embodiment, the design of the spiral needle seat 21 takes into account the interaction with the push rod device 3, especially in the direction facing the second end of the injection sleeve 1, the spiral needle seat 21 is equipped with a slot structure 212. The design purpose of this slot structure 212 is to provide a mechanical locking point. When the push rod device 3 is pushed in from the first end of the injection sleeve 1 and is fully in place, the corresponding structure on the push rod device 3 can be locked with the slot structure 212. At this time, the push rod device 3 is connected to the needle device 2 as a whole, so as to realize the function of needle retraction.

[0086] Please continue to refer to Figure 4 and Figure 5 In some embodiments, the push rod device 3 includes a first rod body 321 having a clamping structure 35 and a stop structure 33 at the first end, and the clamping structure 35 is used to be clamped and fixed with the slot structure 212 after inserting into the spiral needle seat 21; the push rod device 3 also includes a second rod body 322 connected to the second end of the first rod body 321 through a pre-breaking structure 34 at the first end.

[0087] On the one hand, after the spiral needle seat 21 is installed with the needle, the spiral needle seat 21 is subjected to the first force F1 caused by the puncture of the needle; the spiral needle seat 21 is subjected to the second force F2 caused by the assembly of the injection sleeve 1 (including the interference fit connection point); the first force F1 is not greater than the second force F2.

[0088] Specifically, when the spiral needle holder 21 is installed with a needle, it will be subjected to a first force F1 under the puncture action of the needle. This force is the force required for the needle to penetrate the skin or other media. At the same time, due to the interference fit between the spiral needle holder 21 and the injection sleeve 1, a second force F2 will be generated, and this fit ensures the stability and sealing of the spiral needle holder 21. Here, the first force F1 is designed to be no greater than the second force F2 to ensure that the structural integrity of the syringe will not be affected during the puncture process.

[0089] On the other hand, after the clamping head structure 35 is clamped into the clamping slot structure 212 , the spiral needle seat 21 is pulled by the first rod body 321 and the third force F3 is greater than the second force F2 .

[0090] Specifically, after the clamping head structure 35 is clamped into the clamping slot structure 212, the spiral needle seat 21 is pulled by the first rod 321, generating a third force F3. The third force F3 is designed to be greater than the second force F2, so as to ensure that when the spiral needle seat 21 is pulled back, the spiral needle seat 21 can be separated from the interference fit position with the injection sleeve 1, so as to achieve the retraction of the needle.

[0091] On the other hand, the fourth force F4 when the pre-breaking structure 34 breaks; the fifth force F5 when the stopping structure 33 is blocked by the blocking structure 11; the fourth force F4 is greater than the third force F3, and the fourth force F4 is less than the fifth force F5.

[0092] Specifically, when the pre-break structure 34 needs to break to realize the self-destruction function of the syringe, it will be subjected to a fourth force F4. This force is generated when the push rod device 3 is pulled out and the self-destruction mechanism is triggered. The fourth force F4 is designed to be greater than the third force F3 to ensure that the pre-break structure 34 remains intact and does not break during the retreat of the spiral needle seat 21.

[0093] When the stop structure 33 is blocked by the blocking structure 11, a fifth force F5 is generated. This force is generated when the push rod device 3 attempts to be pulled out but is restricted by the blocking structure 11. The fifth force F5 is the maximum force in the design, and the fracture design of the pre-break structure 34 must ensure that the fourth force F4 is less than this force, so as to ensure that the stop structure 33 can effectively trigger the fracture of the pre-break structure 34 during normal use and self-destruction.

[0094] In this embodiment, after the clamping head structure 35 is clamped into the clamping slot structure 212, the syringe has been self-destructed and cannot be used again. After the pre-breaking structure 34 is broken, the syringe is further destroyed, and the injection needle is clamped inside the injection sleeve 1, achieving safety and preventing accidental collision.

[0095] Please refer to Figure 7 , Figure 7 for Figure 2 Magnified view of the mid-needle assembly.

[0096] In some embodiments, the push rod device 3 includes a push head member 31 and a push rod member 32 having a first rod body 321. The first end of the first rod body 321 is provided with a clamping structure 35, a mounting structure 36 and a stopping structure 33 in sequence. The push head member 31 is sleeved on the mounting structure 36. The push head member 31 is provided with a through hole for the clamping structure 35 to pass through.

[0097] In this embodiment, the assembly of the push rod device 3 mainly involves the combination of the push head member 31 and the push rod member 32, and its design has significant advantages. The push head member 31 can be integrally formed, which means that the first rod body 321, the second rod body 322, the stop structure 33, the pre-break structure 34, the clamping structure 35 and the mounting structure 36 are integrally formed during the manufacturing process. This integral molding process simplifies the assembly process because no additional steps are required to connect these components, thereby reducing assembly time and improving production efficiency.

[0098] In addition, the push head 31 is mounted on the mounting structure 36 of the push rod 32. This design allows the push rod device 3 to move smoothly inside the syringe, ensuring the smoothness of the injection process. At the same time, the through hole on the push head 31 provides a precise guide for the clamping structure 35, simplifying the assembly process of the push head 31 and the push rod 32.

[0099] Please continue to refer to Figure 1 In some embodiments, the push rod device 3 includes a push rod member 32 and a stop structure 37 detachably arranged on the push rod member 32. The stop structure 37 is located outside the injection sleeve 1. The stop structure 37 is used to prevent the push rod device 3 from being accidentally pushed by contacting the injection sleeve 1 when it is not removed, thereby preventing the syringe from self-destructing.

[0100] In this embodiment, the design of the push rod device 3 particularly includes a removable stop structure 37, which is located outside the injection sleeve 1. The main function of the stop structure 37 is to prevent any accidental pushing of the push rod device 3 by contacting the injection sleeve 1 before the syringe is used.

[0101] The advantage of this design is that it provides an additional safety mechanism to prevent accidental insertion when the syringe is used for the first time, which would render the entire product ineffective and unable to be used again, similar to an insurance function. In addition, the stop structure 37 is easy to remove, so that when the syringe is actually used, the medical staff can quickly remove the stop structure 37 and perform normal injection operations.

[0102] In some cases, the blocking structure 11 is designed in a ring type, and the blocking structure 11 can be provided with two circles. The stop structure 33 can be designed as two sets of steps and a recessed ring between the steps, so that the blocking structure 11 is sunken into the stop structure 33, thereby enhancing the bonding strength between the blocking structure 11 and the stop structure 33. In addition, a larger number of blocking structures 11 can be provided to avoid the risk of a single stop structure 33 accidentally falling out of the blocking structure 11, thereby providing additional protection.

[0103] In some cases, the first force F1 is set to be less than 25N, and the third force F3 is set to be greater than or equal to 25N.

[0104] It should be noted that many of the components mentioned in this application are universal standard parts or components known to those skilled in the art, and their structures and principles can be learned by those skilled in the art through technical manuals or through conventional experimental methods.

[0105] It should be noted that, in this specification, relational terms such as first and second are merely used to distinguish one entity from other entities, but do not necessarily require or imply any actual relationship or order between these entities.

[0106] The above is a detailed introduction to the safety self-destructive syringe provided by the present application. The principles and implementation methods of the present application are described in detail using specific examples herein, and the description of the above embodiments is only used to help understand the method and core idea of ​​the present application. It should be pointed out that for those skilled in the art, without departing from the principles of the present application, several improvements and modifications can be made to the present application, and these improvements and modifications also fall within the scope of protection of the claims of the present application.

Claims

1. A safe self-destructive syringe, characterized in that: include: An injection sleeve having a first end and a second end in communication with the interior thereof; A needle device is mounted on the first end of the injection sleeve, and the needle device is sealed and connected to the injection sleeve; A push rod device is inserted into the injection sleeve from the second end of the injection sleeve, the push rod device is in sealing contact with the injection sleeve and forms a sealed solution space between the needle device and the push rod device; Wherein, the second end of the injection sleeve is provided with a blocking structure, and the blocking structure is used to break the push rod device when the push rod device is pulled out from the second end of the injection sleeve.

2. The safety self-destructive syringe according to claim 1, characterized in that: The push rod device comprises: A push head member, in sealing contact with the injection sleeve; A push rod member is connected to the push head member, and the push rod member is used to break when the push rod member is pulled out from the second end of the injection sleeve.

3. The safety self-destructive syringe according to claim 2, characterized in that: The push rod member is provided with a stop structure and a pre-break structure, wherein the stop structure is used to be restricted by the blocking structure when the push rod member is pulled out from the second end of the injection sleeve, so as to break the pre-break structure.

4. The safety self-destructive syringe according to claim 3, characterized in that: The push rod member includes a first rod body and a second rod body, the first end of the first rod body is connected to the push head member, the first rod body is provided with the stopping structure, the second end of the first rod body is connected to the first end of the second rod body through the pre-breaking structure, and the second end of the second rod body is located outside the injection sleeve.

5. The safety self-destructive syringe according to claim 1, characterized in that: The needle device comprises: The spiral needle seat is sealed and connected to the injection sleeve. The spiral needle seat is provided with a threaded hole for mounting a needle in a direction away from the second end of the injection sleeve.

6. The safety self-destructive syringe according to claim 5, characterized in that: The spiral needle seat is assembled with the injection sleeve; The spiral needle seat and the injection sleeve are interference fit, and / or a connection point is provided at the assembly position of the spiral needle seat and the injection sleeve.

7. The safety self-destructive syringe according to claim 6, characterized in that: The spiral needle seat is provided with a slot structure in the direction facing the second end of the injection sleeve, and the slot structure is used to be buckled and fixed with the push rod device when the push rod device is pushed into place toward the first end of the injection sleeve.

8. The safety self-destructive syringe according to claim 7, characterized in that: The push rod device comprises a first rod body provided with a clamping head structure and a stopper structure at the first end, wherein the clamping head structure is used to be clamped and fixed with the clamping slot structure after being inserted into the spiral needle seat; The push rod device also includes a second rod body connected to the second end of the first rod body through a pre-breaking structure at a first end; Wherein, after the needle is installed on the spiral needle seat, the first force acting on the spiral needle seat due to the needle puncture is F1; the second force acting on the spiral needle seat due to the injection sleeve assembly is F2; ​​the first force F1 is not greater than the second force F2; After the clamping head structure is clamped into the clamping slot structure, the third force acting on the spiral needle seat under the pulling action of the first rod body is F3; the third force F3 is greater than the second force F2; The fourth force when the pre-breaking structure breaks is F4; the fifth force on the stopping structure blocked by the blocking structure is F5; the fourth force F4 is greater than the third force F3, and the fourth force F4 is less than the fifth force F5.

9. The safety self-destructive syringe according to claim 1, characterized in that: The push rod device includes a push head member and a push rod member provided with a first rod body, the first end of the first rod body is provided with a clamping structure, a mounting structure and a stopping structure in sequence, the push head member is sleeved on the mounting structure, and the push head member is provided with a through hole for the clamping structure to pass through.

10. The safety self-destructive syringe according to any one of claims 1 to 9, characterized in that: The push rod device includes a push rod member and a stop structure detachably arranged on the push rod member, wherein the stop structure is located outside the injection sleeve and is used to prevent the push rod device from being accidentally pushed by contacting the injection sleeve when it is not removed.